PolyPeptide Group AG Financials

Market Capitalization CHF923.5 Million as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	108.52
Forward PE	75.68
Price to Sales TTM	CHF2.85
Price to Book MRQ	CHF2.57
Enterprise to Revenue	3.06
Enterprise to EBITDA	2216.73

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2023-12-31
Profit Margin	-8.83%
Operating Margin	-9.31%
Return on Assets TTM	-2.34%
Return on Equity TTM	-7.68%

Income Statement

Revenue TTM	CHF300,328,461
Revenue per Share TTM	CHF9.89
Quarterly Revenue Growth	2.40%
Gross Profit TTM	CHF4,642,000
EBITDA	CHF414,878
Net Income to Common TTM	CHF-26,507,678
Diluted EPS TTM	CHF-0.81
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	CHF44,991,586
Total Cash per Share MRQ	CHF1.47
Total Debt MRQ	CHF
Total Debt to Equity MRQ	32.18
Current Ratio MRQ	1.59
Book Value per Share MRQ	CHF10.91

Cash Flow

Operating Cash Flow TTM	CHF79,149,922
Levered Free Cash Flow TTM	CHF9,473,524

PPGN Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	32,983,600
Float Shares	12,955,965
Avg 10 Volume	17,715
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	60.41%
% Held by Institutions	20.46%

Stock Price Summary

Beta	1.12
Fifty Two Week Low	CHF14.56
Fifty Two Week High	CHF35.80
Fifty Two Week Change	40.78%
Day 50 MA	CHF28.94
Day 200 MA	CHF29.41

Dividends and Splits

Forward Annual Dividend Rate	CHF
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	CHF0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date	2022-05-02
Ex Dividend Date	2022-04-28
Last Split Factor
Last Split Date